Novartis AG
Novartis's GHG Emissions Data Preview
In 2024, Novartis completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Novartis has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Novartis's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Novartis amounted to 407,400 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Novartis decreased by 8.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Novartis's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Novartis's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Novartis were 207,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Novartis reduced its Scope 1 emissions over time?
Since 2018, Novartis's Scope 1 emissions have decreased by 56.88%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Novartis's Scope 1 emissions decreased by 17.56%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Novartis's Scope 2 emissions?
In 2024, Novartis reported Scope 2 greenhouse gas (GHG) emissions of 30,000 tCOâ‚‚e using the market-based method, and 200,400 tCOâ‚‚e using the location-based method.
Has Novartis reduced its Scope 2 emissions over time?
Since 2018, Novartis's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 62.19%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Novartis's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Novartis 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Novartis use for Scope 2 reporting?
In 2024, Novartis reported its Scope 2 emissions using the market-based method and using the location-based method.
Novartis's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Novartis's Value Chain Emissions
In 2024, Novartis reported 4,350,300 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Novartis includes a breakdown across 12 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Novartis's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Novartis's Scope 3 emissions?
In 2024, Novartis reported total Scope 3 emissions of 4,350,300 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 95.77% of these emissions originated from upstream activities such as purchased goods and capital goods, while 4.23% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Novartis reduced its Scope 3 emissions over time?
Since 2018, Novartis's Scope 3 emissions have decreased by 21.46%, reflecting a declining long-term trend in Scope 3 emissions over time.
Compared to the previous year (2023), Novartis's Scope 3 emissions remained relatively stable, indicating that Novartis 's emissions have plateaued with no significant change in its value chain footprint.
What categories of Scope 3 emissions does Novartis disclose?
In 2024, Novartis reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Novartis's Scope 3 emissions?
In 2024, the largest contributors to Novartis's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 3,372,500 tCOâ‚‚e (77.52%)
- Capital Goods (Cat. 2): 195,700 tCOâ‚‚e (4.5%)
- Upstream Transportation and Distribution (Cat. 4): 166,000 tCOâ‚‚e (3.82%)
Novartis's Scope 3 Emissions by Categories
Insights into Novartis's Total Carbon Footprint
In 2024, Novartis reported a total carbon footprint of 4,757,700 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.22% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Novartis's total carbon footprint was Scope 3 emissions, accounting for 91.44% of the company's total carbon footprint, followed by Scope 1 emissions at 4.35%.